Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
JERUSALEM, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the execution of an agreement for the marketing and distribution of its Deep TMS device in Nordic...
-
JERUSALEM, Aug. 21, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA) is pleased to announce that, further to its press release of November 1, 2011, the Company has contracted with 18 medical research...
-
JERUSALEM, July 24, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received approval from Israel's Ministry of Health to test the efficacy of its Deep TMS...
-
JERUSALEM, July 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to a clinical trial being conducted at the Sheba Medical...
-
JERUSALEM, July 2, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received CE Mark enabling commercialization of its Deep TMS system to treat neuropathic...
-
JERUSALEM, April 18, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce positive results from its double-blind multicenter clinical trial for the assessment of the safety and...
-
JERUSALEM, Feb. 23, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received the Frost & Sullivan 2012 Global New Product Innovation Award in...
-
JERUSALEM, Feb. 21, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received the final results of a clinical trial performed by Advanced Technologies Innovation...
-
JERUSALEM, Jan. 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that, on January 1st, 2012, it entered into an exclusive agreement for the distribution of the Deep TMS...
-
JERUSALEM, Dec. 28, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to 26 patients from a double-blinded clinical trial...